BioCentury
ARTICLE | Clinical News

Revlimid lenalidomide regulatory update

July 25, 2016 7:00 AM UTC

The European Commission approved an expanded label for Revlimid lenalidomide from Celgene to include the treatment of adults with relapsed or refractory mantle cell lymphoma (MCL). The thalidomide ana...